RULONILIMAB
UNII KQA6N2NT4Z

Substance Identification & Data

This profile provides standardized clinical and technical data for Rulonilimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) KQA6N2NT4Z.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2417124-95-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

KQA6N2NT4Z

CAS Registry Number

2417124-95-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

RULONILIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C162636

National Cancer Institute reference terminology for clinical and research data.

INN ID

11710

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Rulonilimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

RULONILIMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1 (251-GLUTAMINE,298-ALANINE,429-LEUCINE), ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN-MUS MUSCULUS MONOCLONAL F520 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL F520 .KAPPA.-CHAIN, DIMER

RULONILIMAB [INN]

RULONILIMAB [WHO-DD]

External Clinical & Regulatory Resources

Previous UNIIKQA442BL6W

Next UNIIKQC2G649WJ